53 related articles for article (PubMed ID: 25384028)
1. Fluorescent non-peptidic RGD mimetics with high selectivity for αVβ3 vs αIIbβ3 integrin receptor: novel probes for in vivo optical imaging.
Alsibai W; Hahnenkamp A; Eisenblätter M; Riemann B; Schäfers M; Bremer C; Haufe G; Höltke C
J Med Chem; 2014 Dec; 57(23):9971-82. PubMed ID: 25384028
[TBL] [Abstract][Full Text] [Related]
2. Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.
Cao J; Wan S; Tian J; Li S; Deng D; Qian Z; Gu Y
Contrast Media Mol Imaging; 2012; 7(4):390-402. PubMed ID: 22649045
[TBL] [Abstract][Full Text] [Related]
3. A new optical imaging probe targeting αVβ3 integrin in glioblastoma xenografts.
Lanzardo S; Conti L; Brioschi C; Bartolomeo MP; Arosio D; Belvisi L; Manzoni L; Maiocchi A; Maisano F; Forni G
Contrast Media Mol Imaging; 2011; 6(6):449-58. PubMed ID: 22144022
[TBL] [Abstract][Full Text] [Related]
4. Studies of tricyclic piperazine/piperidine furnished molecules as novel integrin αvβ3/αIIbβ3 dual antagonists using 3D-QSAR and molecular docking.
Yan Y; Li Y; Zhang S; Ai C
J Mol Graph Model; 2011 Feb; 29(5):747-62. PubMed ID: 21273104
[TBL] [Abstract][Full Text] [Related]
5. Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and α(IIb)β3 integrin-rich intact cells by NMR and computational studies.
Guzzetti I; Civera M; Vasile F; Araldi EM; Belvisi L; Gennari C; Potenza D; Fanelli R; Piarulli U
Org Biomol Chem; 2013 Jun; 11(23):3886-93. PubMed ID: 23657523
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro, and in vivo characterization of an integrin alpha(v)beta(3)-targeted molecular probe for optical imaging of tumor.
Burnett CA; Xie J; Quijano J; Shen Z; Hunter F; Bur M; Li KC; Danthi SN
Bioorg Med Chem; 2005 Jun; 13(11):3763-71. PubMed ID: 15863003
[TBL] [Abstract][Full Text] [Related]
7. Novel α(2)β(1) integrin-targeted peptide probes for prostate cancer imaging.
Huang CW; Li Z; Cai H; Shahinian T; Conti PS
Mol Imaging; 2011 Aug; 10(4):284-94. PubMed ID: 21486537
[TBL] [Abstract][Full Text] [Related]
8. Optimizing the bioavailability of small molecular optical imaging probes by conjugation to an albumin affinity tag.
Hahnenkamp A; Alsibai W; Bremer C; Höltke C
J Control Release; 2014 Jul; 186():32-40. PubMed ID: 24815420
[TBL] [Abstract][Full Text] [Related]
9. Functionalized cyclic RGD peptidomimetics: conjugable ligands for αvβ3 receptor imaging.
Arosio D; Manzoni L; Araldi EM; Caprini A; Monferini E; Scolastico C
Bioconjug Chem; 2009 Aug; 20(8):1611-7. PubMed ID: 21141806
[TBL] [Abstract][Full Text] [Related]
10. Indocyanine green-containing nanostructure as near infrared dual-functional targeting probes for optical imaging and photothermal therapy.
Zheng X; Xing D; Zhou F; Wu B; Chen WR
Mol Pharm; 2011 Apr; 8(2):447-56. PubMed ID: 21197955
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
12. In vivo imaging of integrin alpha v beta 3 expression using fluorescence-mediated tomography.
von Wallbrunn A; Höltke C; Zühlsdorf M; Heindel W; Schäfers M; Bremer C
Eur J Nucl Med Mol Imaging; 2007 May; 34(5):745-754. PubMed ID: 17131149
[TBL] [Abstract][Full Text] [Related]
13. Discrete functional motifs reside within the cytoplasmic tail of alphaV integrin subunit.
Haas TA
Thromb Haemost; 2008 Jan; 99(1):96-107. PubMed ID: 18217140
[TBL] [Abstract][Full Text] [Related]
14. Multiple N-methylation by a designed approach enhances receptor selectivity.
Chatterjee J; Ovadia O; Zahn G; Marinelli L; Hoffman A; Gilon C; Kessler H
J Med Chem; 2007 Nov; 50(24):5878-81. PubMed ID: 17973471
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors.
Ye Y; Bloch S; Xu B; Achilefu S
J Med Chem; 2006 Apr; 49(7):2268-75. PubMed ID: 16570923
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
McQuade P; Knight LC; Welch MJ
Bioconjug Chem; 2004; 15(5):988-96. PubMed ID: 15366951
[TBL] [Abstract][Full Text] [Related]
17. A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword.
Shuhendler AJ; Prasad P; Leung M; Rauth AM; Dacosta RS; Wu XY
Adv Healthc Mater; 2012 Sep; 1(5):600-8. PubMed ID: 23184795
[TBL] [Abstract][Full Text] [Related]
18. Enhancing surgical vision by using real-time imaging of αvβ3-integrin targeted near-infrared fluorescent agent.
Themelis G; Harlaar NJ; Kelder W; Bart J; Sarantopoulos A; van Dam GM; Ntziachristos V
Ann Surg Oncol; 2011 Nov; 18(12):3506-13. PubMed ID: 21509632
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of competition binding assays for affinity to the extracellular matrix receptors, α(v)β(3) and α(IIb)β(3) integrin.
Szabo AM; Howell NR; Pellegrini P; Greguric I; Katsifis A
Anal Biochem; 2012 Apr; 423(1):70-7. PubMed ID: 22285979
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of a near-infrared fluorescent non-peptidic bivalent integrin alpha(v)beta(3) antagonist for cancer imaging.
Li F; Liu J; Jas GS; Zhang J; Qin G; Xing J; Cotes C; Zhao H; Wang X; Diaz LA; Shi ZZ; Lee DY; Li KC; Li Z
Bioconjug Chem; 2010 Feb; 21(2):270-8. PubMed ID: 20102181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
